AMA survey finds economic, patient-care impact of Change Healthcare cyber-attack ongoing
April 10, 2024
Life After Change Cyber-attack: Without Payment for Claims, Physicians Struggle to Keep Practices Afloat
April 10, 2024 — The American Medical Association (AMA) released informal survey findings (PDF) showing the ongoing,…
Read More
A new technology using ultralow temperature cryoablation (ULTC), developed by Adagio Medical, has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science was presented this week during EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).
April 10, 2024
Cryocure-VT Trial Outcomes Presented in EHRA 2024 Late-Breaking Science Session
April 10, 2024 — A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular…
Read More
An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
April 10, 2024
News from EHRA 2024: International Experts Agree on Standards for Catheter Ablation of Atrial Fibrillation
April 10, 2024 — An international consensus statement on how to treat atrial fibrillation with catheter or surgical…
Read More
Study found no difference in troponin biomarkers up to one month after anthracycline treatment
April 09, 2024
ACE Inhibitor Not Protective Against Heart Damage from Chemotherapy
April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment…
Read More
Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as the organization’s first non-physician president.
April 09, 2024
Cathie Biga is New American College of Cardiology President
April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history…
Read More
UC Davis is one of the first sites nationwide to treat tricuspid regurgitation using a minimally invasive catheter system
April 09, 2024
Cardiology Team Performs Novel Heart Artery Repair with Newly Approved Device
April 9, 2024 — UC Davis Health cardiology team members are among the first in the country to treat patients with …
Read More
Subanalysis finds benefit for patients not on heart-beneficial antidiabetic medication
April 09, 2024
New Drug Fails to Improve Diabetes-Related Heart Failure
April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes…
Read More
Phase 2 trial shows early signs that the investigational drug could relieve symptoms and improve exercise capacity in HCM patients with no other evidence-based treatment options available
April 09, 2024
Ninerafaxstat Well-Tolerated and Safe for Nonobstructive Hypertrophic Cardiomyopathy
April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with…
Read More
Trial shows increased risk of bleeding with topical administration during open heart surgery
April 09, 2024
Topical Tranexamic Acid Found Inferior to Intravenous Administration
April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically…
Read More
Participants saw 35% reduction in LDL cholesterol, signaling the process could offer safe, effective non-prescription use of life-saving drug
April 09, 2024
Study Shows Web App Effective in Determining Access to Statins Without a Prescription
April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely…
Read More
First head-to-head comparison of leading valve types finds better valve performance with selfexpanding valve and non-inferior clinical outcomes at one year
April 09, 2024
Self-Expanding Valve Outperforms Balloon-Expandable Valve for TAVR in Patients with Small Valve Annulus
April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the…
Read More
Infusions reduce lead levels but show no effect on clinical endpoints
April 08, 2024
Chelation Therapy Does Not Improve Outcomes after Heart Attack
April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-…
Read More
Study suggests routine use is likely unnecessary for those with normal ejection fraction
April 08, 2024
Beta Blockers May Not Benefit Many Heart Attack Survivors
April 8, 2024 — Taking beta blockers after a heart attack did not significantly reduce the risk of death or a second…
Read More
Mechanical circulatory support boosts survival in cardiogenic shock patients, despite risks
April 08, 2024
Heart Pump Improves Survival After Severe Heart Attacks
April 8, 2024 — Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly…
Read More
Ticagrelor alone outperforms 12-month DAPT for reducing bleeding with no increased risk
April 08, 2024
Study Suggests Most Patients with Acute Coronary Syndromes Can Safely Stop Aspirin One Month After Percutaneous Coronary Intervention
April 8, 2024 — People who have had a heart attack or who are at risk for a heart attack and who stopped taking aspirin…
Read More
Earning points or small sums of money encourages people to ‘step up’ their physical activity
April 07, 2024
Incentives Prompt Increased Daily Walking in Patients at Risk for Heart Disease
April 7, 2024 — Strategies such as earning points or small amounts of money encouraged people at high risk for heart…
Read More
When added to standard blood pressure medication, new drug could minimize the need for pills and reduce cardiovascular risks
April 07, 2024
One Injection of Novel Drug Cuts Systolic Blood Pressure by Up to 12 mmHg
April 7. 2024 — A single subcutaneous injection of the investigational drug zilebesiran, when added to existing…
Read More
Results show drug is effective and safe, leaves open question of optimal dosing
April 07, 2024
Study Finds Olezarsen Cuts Triglyceride Levels by About Half
April 7, 2024 — An estimated 1 in 5 U.S. adults—and more than 2 in 5 adults aged 60 years and older—have elevated…
Read More
90% of high-risk patients on lerodalcibep achieved guideline-recommended cholesterol targets
April 07, 2024
Novel PCSK9 Inhibitor Cut LDL Cholesterol Levels by More Than Half
April 7, 2024 — Among patients at high or very high risk for a heart attack or stroke, the addition of the…
Read More
Novel drug shows promise for treating severe hypertriglyceridemia in patients at high risk for pancreatitis
April 07, 2024
Plozasiran Reduces Triglyceride Levels by 74% at 24 Weeks
April 7, 2024 — In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now